LONDON, May 30 (Reuters) - The Wellcome Trust medical charity is to profit from U.S. approval of a new diagnostic cancer test, the first commercial product funded by the organisation since the sale of its pharmaceuticals business to Glaxo in 1995.
from Reuters: New Issues News http://ift.tt/1TQvDaM
Tidak ada komentar:
Posting Komentar